Compare RYTM & WIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | WIX |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 2017 | 2013 |
| Metric | RYTM | WIX |
|---|---|---|
| Price | $88.26 | $48.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 22 |
| Target Price | $131.14 | ★ $134.67 |
| AVG Volume (30 Days) | 491.0K | ★ 2.5M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.34 | $15.80 |
| Revenue Next Year | $86.06 | $13.21 |
| P/E Ratio | ★ N/A | $28.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.71 | $46.90 |
| 52 Week High | $122.20 | $190.92 |
| Indicator | RYTM | WIX |
|---|---|---|
| Relative Strength Index (RSI) | 49.80 | 33.88 |
| Support Level | $87.19 | N/A |
| Resistance Level | $92.51 | $93.82 |
| Average True Range (ATR) | 3.56 | 3.86 |
| MACD | -0.24 | -0.14 |
| Stochastic Oscillator | 49.10 | 9.91 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years it has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.